SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950136-08-001374
Filing Date
2008-03-17
Accepted
2008-03-17 17:12:35
Documents
14
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K file1.htm 10-K 3658740
2 UNPROTECTED LEASE file2.htm EX-10.21 156268
3 CONSENT OF PWC file3.htm EX-23.1 5290
4 CERTIFICATION OF CEO SECTION 302 file4.htm EX-31.1 15661
5 CERTIFICATION OF CFO SECTION 302 file5.htm EX-31.2 15600
6 CERTIFICATION OF CEO SECTION 906 file6.htm EX-32.1 5100
7 CERTIFICATION OF CFO SECTION 906 file7.htm EX-32.2 5104
8 ebox.gif GRAPHIC 58
9 xbox.gif GRAPHIC 63
10 spacer.gif GRAPHIC 43
11 html_301629chart3.jpg GRAPHIC 47815
12 html_pwclogo.jpg GRAPHIC 6434
13 html_301629linegraph.jpg GRAPHIC 31903
14 html_301629bargraph.jpg GRAPHIC 20840
  Complete submission text file 0000950136-08-001374.txt   4012081
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33357 | Film No.: 08693900
SIC: 2836 Biological Products, (No Diagnostic Substances)